Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $561.1K | $191.7K | $342.6K | $224.5K | $117.6K | $182.2K | $238.9K |
| Operating income | −$1.1M | −$1.3M | −$1.1M | −$1.3M | −$853.2K | −$1.7M | −$429.8K | −$647.7K |
| EBITDA | −$1.1M | −$1.0M | −$1.1M | −$1.5M | −$853.2K | −$2.0M | −$429.8K | −$595.7K |
| Net income | −$1.2M | −$25.1M | −$1.1M | −$973.8K | −$853.2K | −$2.0M | −$443.8K | −$577.1K |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -1.41 | -2.41 | -0.05 | -0.04 | -0.04 | -0.08 | -0.01 | -0.02 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds EQUR.
No tracked institution reports a position in EQUR as of their last filing.
No one on the platform has traded EQUR yet.
| +9900.00% |
| $6493 |
| — |
| FPSUFCapha Pharmaceuticals Inc. | $0.00 | +0.00% | $6443 | — |
| GLSHQGelesis Holdings, Inc. | $0.00 | +0.00% | $7334 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.